Gabriel Ferreira, MD
Ophthalmology · New York, NYNPI 1023389871
Payments from drug & device makers
Across 564 payments — averaging $30.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$3K
- Alcon$2K
- AbbVie$2K
- Bausch & Lomb Americas Inc.$2K
- Novartis$710
- Oyster Point Pharma, Inc.$694
- plus $6K from 23 others
What the payments were for
- Consulting fees$1,3508%
- Speaking & faculty fees$1221%
- Food & beverage$15,26990%
- Education$1181%
- Other$1401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 18 | $2,575 |
| Alcon | 95 | $2,410 |
| AbbVie(2 entities) | 125 | $2,297 |
| Bausch & Lomb Americas Inc. | 52 | $2,018 |
| Novartis | 48 | $710 |
| Oyster Point Pharma, Inc. | 18 | $694 |
| Harrow Eye, LLC | 23 | $670 |
| Biotissue Holdings Inc. | 36 | $647 |
| Aerie Pharmaceuticals, Inc. | 10 | $627 |
| Eyevance Pharmaceuticals LLC | 11 | $555 |
| Abbott | 15 | $536 |
| Mallinckrodt Hospital Products Inc. | 13 | $532 |
| Sun Pharmaceutical Industries Inc. | 33 | $521 |
| Sight Sciences, Inc. | 3 | $284 |
| Ocular Therapeutix, Inc. | 10 | $271 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $257 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $227 |
| Amgen(2 entities) | 10 | $214 |
| Dompe US, Inc. | 8 | $187 |
| Alimera Sciences, Inc. | 1 | $150 |
| NEW World Medical,inc. | 1 | $140 |
| Thea Pharma Inc. | 5 | $115 |
| Tarsus Pharmaceuticals, Inc. | 5 | $95 |
| Kala Pharmaceuticals, Inc. | 5 | $90 |
| Boehringer Ingelheim | 2 | $50 |
| Rayner Intraocular Lenses Limited | 2 | $41 |
| Astellas Pharma US Inc | 2 | $32 |
| Eyepoint US, Inc. | 2 | $26 |
| Shire North American Group Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Travoprost Intraocular Implant - iDose$1,350
- Rocklatan$494
- enVista MX60 IOL$466
- Rhopressa$369
- Radius XR$303
- Zerviate$285
- OMNI(R) SURGICAL SYSTEM (US)$271
- iDoseTR$270
- TYRVAYA$258
- TORIC$255
- Hydrus Microstent$247
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$236
- iDose$167
- Iluvien$150
- XEN GLAUCOMA TREATMENT SYSTEM$147
- Clareon PanOptix Pro$146
- Kahook Dual Blade$140
- Streamline Surgical System$140
- Ahmed Glaucoma Valve$140
- LUMIGAN$125
How this compares
$16,999 in reported general payments places this provider in the 85th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 490 | $591,693 |
| OxervateCenegermin-Bkbj | 16 | $461,989 |
| RestasisCyclosporine | 300 | $328,282 |
| LumiganBimatoprost | 302 | $154,854 |
| ProlensaBromfenac Sodium | 421 | $140,763 |
| CequaCyclosporine | 126 | $121,070 |
| CombiganBrimonidine Tartrate/Timolol | 267 | $110,020 |
| RhopressaNetarsudil Mesylate | 223 | $92,677 |
| EysuvisLoteprednol Etabonate | 162 | $77,099 |
| MieboPerfluorohexyloctane/Pf | 70 | $58,414 |
| Prednisolone Acetate | 1,185 | $57,401 |
| TyrvayaVarenicline Tartrate | 85 | $53,496 |
| DurystaBimatoprost | 20 | $41,353 |
| Alphagan PBrimonidine Tartrate | 87 | $34,187 |
| Brimonidine Tartrate | 489 | $31,399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra, Miebo, Vyzulta | $2,018 | $675,244610 claims |
| AbbVieRestasis, Lumigan, Combigan, Durysta, Alphagan P | $2,297 | $668,696976 claims |
| Dompe US, Inc.Oxervate | $187 | $461,98916 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Alrex | $257 | $148,972445 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $521 | $121,070126 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $627 | $103,497256 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $90 | $77,099162 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $694 | $53,49685 claims |
| AlconSimbrinza | $2,410 | $13,79063 claims |
| Harrow Eye, LLCVevye | $670 | $12,97118 claims |
| Thea Pharma Inc.Iyuzeh | $115 | $11,81128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,587 ophthalmology providers in New York.
Other ophthalmology in New York
- Douglas JabsNew York$24.3M
- Nathan RadcliffeNew York$2.4M
- Richard SpaideNew York$1.7M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
- Sharon KehNew York$941K
- Joshua YoungNew York$814K
- Joseph PanarelliNew York$704K
- Joshua KimNew York$677K
- Eric RosenbergNew York$526K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.